ACM
DGX icon

Aster Capital Management’s Quest Diagnostics DGX Stock Holding History

Aster Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$529K Buy
+2,497
New +$490K 0.11% 254
2025
Q3 		– Sell
-23
Closed -$4.13K – 1054
2025
Q2 		$4.13K Sell
23
-9,106
-100% -$1.58M ﹤0.01% 887
2025
Q1 		$1.58M Buy
9,129
+9,123
+152,050% +$1.5M 0.29% 88
2024
Q4 		$905 Sell
6
-564
-99% -$87.7K ﹤0.01% 1016
2024
Q3 		$88.5K Buy
+570
New +$85.1K 0.02% 392

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Aster Capital Management's DGX Position: Q2 2026 in Review

Aster Capital Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 2,497 shares worth $529K. The stake represents 0.11% of the portfolio and ranks #254 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in DGX as recently as Q2 2025.

Aster Capital Management first reported a position in DGX in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.58M in Q1 2025. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Aster Capital Management held 2,497 shares of Quest Diagnostics worth $529K as of Q2 2026.
  • Quest Diagnostics was a new Aster Capital Management position in Q2 2026.
  • Quest Diagnostics made up 0.11% of Aster Capital Management's portfolio in Q2 2026, its #254 holding.
  • Aster Capital Management first reported a position in Quest Diagnostics in Q3 2024 and has held it in 5 quarters since.
  • Aster Capital Management's Quest Diagnostics position peaked at $1.58M in Q1 2025.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.